Constipation, a common gastrointestinal disorder, presents a diagnostic and therapeutic challenge in clinical practice due to its multifaceted nature. Understanding its complexity is pivotal to effective management.
Constipation may be primary, resulting from colonic or anorectal dysfunction, or secondary to systemic diseases, medications, or lifestyle factors. A thorough history and physical examination, including a detailed drug history, can help identify the etiology.
While constipation is primarily a clinical diagnosis, further investigations may be warranted in refractory cases or when alarm features are present. These may include blood tests, imaging, colonic transit studies, anorectal manometry, and defecography.
Management should be individualized based on the underlying cause, severity, and patient preference. Initial steps involve lifestyle modifications, including dietary changes and increased physical activity. Pharmacological interventions such as laxatives are used for short-term relief, whereas prokinetic agents and biofeedback therapy may be considered in chronic cases.
Emerging evidence suggests that gut microbiota modulation using probiotics can improve constipation symptoms. However, further research is required to establish their routine use in clinical practice.
The complex pathophysiology of constipation necessitates ongoing research to identify novel diagnostic and therapeutic targets. The role of genetic factors, gut-brain axis, and microbiota are areas of active exploration.
Constipation management requires a comprehensive, patient-centered approach that considers the multifactorial etiology of the disorder. Future research should focus on elucidating the complex mechanisms underlying constipation, which could pave the way for more effective and personalized treatment strategies.
1.
The need for more Latinx participants in Alzheimer's trials is urgent.
2.
Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa
3.
Disparities in use of MRI to detect prostate cancer: Race and location may influence testing
4.
In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?
5.
Study offers clearer picture of childhood brain tumor survival
1.
Revolutionizing Cancer Care: The Promise of Early Detection and Biomarkers
2.
The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment
3.
Comprehensive Standards in Oncology for Modern Medicine
4.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
5.
Practical Standards in Hematology for Healthcare Excellence
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
4.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation